{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67062ebddb85d85869498f7f/690dc9c7c72b7869e27a1fff?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"AI Talk: AI in the pharmaceutical industry – is your data a strategic asset or a hidden risk?","description":"<p>This is the audio-only version of our weekly AI talk show.&nbsp;Join us every Tuesday for free by visiting www.business-reporter.co.uk/ai-talk</p><p><br></p><p>The panel discussion is titled: </p><p><strong>AI Talk: AI in the pharmaceutical industry – is your data a strategic asset or a hidden risk?</strong></p><p><br></p><ul><li>How AI trends are shaping strategic decisions in the pharmaceutical industry</li><li>High-value use cases, including AI-driven processing of large-scale pharmaceutical documentation</li><li>How responsible AI use in GxP-critical processes can mitigate compliance risk in the US market</li></ul><p><br></p><p>This episode is hosted by Kevin Craine</p><p><strong>https://www.linkedin.com/in/kevincraine/ </strong></p><p>Julie Daves,&nbsp;President &amp; Principal Consultant,&nbsp;<strong>JVD Pharmaceutical Consulting, LLC</strong></p><p>Dave Anderson, CEO,&nbsp;<strong>DataCompass</strong></p><p>Tomas Van Dorpe, Pre-Sales Architect,&nbsp;<strong>Cegeka&nbsp;</strong></p>","author_name":"Business Reporter"}